Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Recommendation of “Buy” by ...
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) has been assigned an average recommendation of “Buy” from the ...